Five young normal subjects (NS) and six middle-aged patients with chronic, lowoutput, congestive heart failure (HFP) were 
The voluntary, informed consent of the subjects used in this research was obtained prior to the tests. Consent of Air Force personnel was in conformity with Air Force Regulation 169-8. Csrculation, Volume XXXIX, January 1969 acute experimental heart failure in the relatively intact animal with severe myocardial impairment, as well as in the heart-lung preparation. 5' 6 Attempts to demonstrate this response pattern in patients with heart failure, however, have produced conflicting results.7' 8 The recent demonstration, that the application of negative pressure to the lower body (LBNP) provides an effective and practical means to deplete the effective blood volume and lower central venous pressure (CVP), 9, 10 suggested that this may offer a useful device to re-evaluate the circulatory responses of heart failure patients to induced hypovolemia. This study was designed (1) to compare under controlled environmental and test conditions the hemodynamic responses of normal subjects with those of patients with severe, 55 chronic, congestive heart failure to moderate hypovolemia and diminished cardiac filling pressure induced by means of LBNP; (2) to study particularly the changes in cardiac performance to evaluate the potential usefulness of LBNP applications as a treatment regimen for chronic heart failure.
Methods
Five healthy, young, male volunteers, familiar with vascular catheterization and LBNP exposures, were chosen as normal subjects. Their physical characteristics are presented in table 1.
Six middle-aged patients were selected from the in-patient population at the Marion County General Hospital. Selection criteria were: (1) Chronic, advanced (class III-IV, New York Heart Association criteria), congestive heart failure with low cardiac output. (2) Myocardial impairment as the only cause of heart failure; all patients had ischemic heart disease or hypertensive cardiovascular disease as the etiology of their heart failure. (3) Comparison of the pulse and blood pressure changes found in the normal subjects during these LBNP exposures with the changes reported from bleeding studies suggests that over 10 ml per kilogram of body weight (over 760 ml) had been removed from the effective blood volume in the normal subjects. [21] [22] [23] [24] The circulatory changes induced by LBNP in the heart failure patients seem sufficient to conclude that a significant degree of hypovolemia had been induced, but the amount of blood sequestered from the central circulation in this group cannot be estimated with accuracy for three prime reasons: (1) The amount of blood impounded in the lower body may not be equal in the two groups because of the altered vascular and extravascular compliance in patients with heart failure due to congestion and edema and altered neurohumerol activity; (2) because of the increased total blood volume usually associated with heart failure, an equal volume of sequestered blood may not represent an equivalent decrement in effective blood volume and may thus provide a lesser circulatory stress; (3) the cardiovascular system in heart failure patients may respond differently to an equivalent degree of hypovolemia because of the altered activity of the sympathetic nervous system and levels of vasoactive hormones, the administration of drugs affecting the circulation, and local-tissue metabolic changes due to inadequate perfusion.
It is notable that in the present study the magnitudes of the changes of individual values for many of the measured factors in the heart failure patients were similar to those in normal subjects; mean differences from control values were not significant because a few of the individual changes were discrepant and at times divergent. Figure 1 demonstrates the general consistency of the changes in the normal group and the variability of the heart failure patients. CVP fell uniformly and was the only measured factor that changed consistently in this group. Four of the patients with milder degrees of heart failure (class III) showed changes in the other measured factors that were generally similar to the normal patterns, whereas the two patients with advanced failure usually changed similarly and often exhibited a different type of response.
The normal subjects showed consistently a large (270 ml mean) fall in central blood volume during LBNP exposure. Three of the heart-failure patients showed a similar change; the other three demonstrated a rise. LBNP may have produced only an insignificant hypovolemia in these patients, the CBV rise being attributed to random measurement Circulation, Volume XXXIX, January 1969 error. However, other hemodynamic changes are evidence that a significant fall in effective blood volume had occurred, and the CBV rise in one patient was striking and well beyond ordinary measurement error. Although an enhanced peripheral venoconstrictive response to hypovolemia could explain the increased CBV, this has never been demonstrated in heart failure. The rise may also be ascribed to an erroneous measurement of mean transit time due to a redistribution of blood flow. '7 18 The information at hand is not sufficient to discriminate among these possibilities.
Experiments fig. 2 ). The two patients with advanced heart failure exhibited a different response, with little change or rise in SV, CO, and SW in the face of a fall in CVP. This response pattern cannot be attributed to an altered after-load since there was no clear relationship between performance indices and the small diastolic blood pressure changes observed. Although these changes can be interpreted as demonstrating a descending limb on the Frank-Starling curve, this is not a unique explanation. Alteration in neurohumoral activity may have affected the condition of the myocardium and "shifted" these patients to another of the family of performance curves that Sarnoff found in the laboratory animal.6 As has been emphasized recently, if a descending limb is present in the human heart, it must be an inherently unstable condition requiring the intervention of auxiliary inotropic nmechanisms and/or alterations in the peripheral circulation as auxiliary governors of the performance of the heart.33 ' 34 Another factor that may be important is the decrease in chamber size, which probably accompanies depletion of the effective blood volume; a more favorable ventricular tensionpressure relationship will diminish myocardial oxygen consumption and tend to improve the efficiency of the heart. 35 Finally, perhaps filling pressure was actually unchanged in these two patients, and the low CVP measurements were caused by a diminished intrathoracic pressure due to inapparent hyperventilation. This explanation seems unlikely since very vigorous hyperventilation, which is required to produce a significant fall in intrathoracic pressure,36 was never observed, and unpublished experiments in this laboratory showed that hyperventilation (as measured by blood gas changes) is not found during LBNP exposures until hypovolemia is extreme and syncope imminent. Because of the complexities of clinical experimentation, it seems impossible to sort out these effects at present.
This range of reactions to a diminished venous return and filling pressure may explain the occasional successes but passing popularity of earlier attempts to treat chronic congestive heart failure with hypovolemia produced by means of phlebotomy37 38 and inferior vena cava ligation.39 40 It is of interest that LBNP was used for the treatment of heart failure a century ago with some success.4' There seems little reason to expect that hypovolemia produced by any means will provide an effective treatment regimen for most cases of chronic heart failure, although it may prove helpful in the occasional patient with very advanced failure.
